An ITC spokesperson confirmed the development but said the company is “unable to share more details at the current moment as the clinical trials are underway".
Sources, however, indicated that the product was being steered by ITC Life Sciences and Technology Centre (LSTC) in Bengaluru. The spray has the potential to be effective in preventing infection as well as transmission of Covid-19. Internal trials had also found it to be effective against other viruses like common cold. The trials could take about three months, they said. The company has received approvals from ethics committees and is registered with Clinical Trial Registry - India, they added.
Continue reading your story on the app
Continue reading your story in the newspaper
Netflix Needs Its KBC Lest It Lose The India Plot
It began innocuously. On Thursday, Netflix, Inc. had an earnings call for the results of its fourth quarter of 2021. Nidhi Gupta, an analyst with Fidelity Management & Research Co, asked Gregory Peters, chief operating officer and chief product officer, what it was trying to achieve with a (30-60 per cent) price drop in India.
Bulking up IFSC
A wide-ranging and ambitious expansion of its remit is expected in the Budget
‘Rural sales value positive; volumes have declined
Q&A SANJIV MEHTA, chairman and MD of Hindustan Unilever (HUL), considers health, hygiene and wellbeing as the new areas of growth for the fast-moving consumer goods (FMCG) major over the next five years. In an exclusive interview with Sharleen D'Souza and Vishal Chhabria, he shares his expectation of commodity prices cooling off in the second half of 2022 which should lead to the return of volume-led growth. Edited excerpts:
Govt firms asked to declare market value of assets
Measure seen as a bid to boost investor confidence in PSUS
Doing good with emerging technologies
Artificial intelligence, machine learning and data analytics are increasingly being used to drive the social good, reports Shivani Shinde
Companies hope for sops in Budget to boost capex
Indian companies are expecting generous tax Budget that will help them invest more in building capacities in the coming years.
Double-digit loan growth may buoy ICICI Bank profit
ICICI Bank is expected to post a healthy profit for the December quarter (Q3FY22), helped by a double-digit growth in loans, when it reports its earnings on Saturday.
Zomato hits record low, m-cap falls below ₹1trn
Shares of Zomato continued to wilt under selling pressure on Friday, falling 9 per cent on the BSE to ₹113.75, the lowest close since its listing on July 23, 2021.
Shoppers Stop hits 52-week high
Shares of Shoppers Stop ended 5 per cent higher at ₹378.65 on the BSE on Friday in an otherwise weak market after the company reported a strong operational performance for the December quarter (Q3FY22).
Separate 5G band & aviation radar frequency: Airtel
Experts say that unlike the US, India already has a large separation between the two bands
'IT Chapter 2' Is A Big-Screen Fun House
It can be a cheesy thing when a novel is split up and spread out over a handful of films, but Stephen King’s “It” is not one of those books.
State plans norms to curb rampant use of monoclonal antibodies
The rampant use of mono-clonal antibodies on Co-vid patients has prompted the state to frame a protocol on use of the cocktail drug that costs Rs 60,000 to Rs 70,000 per dose.
As cases soar, cry for cocktail cure
As Covid cases across the city soar, so has the demand for cocktail therapy as compared to the second wave.
PICK & CHOOSE
Two vaccines, Covid oral pill get DGCI nod
Cipla launches India's first pneumotach-based wireless spirometer
Cipla’s Spirofy is a result of five years of in-house research by the Integrated Product Development (IPD) team, and it aims to transform OAD diagnosis in India.
THE SHORT SQUEEZE
Replacing toothpaste tubes with tabs can enable the hospitality industry to take a huge cooperative step forward towards sustainability
ऊंची लागत की मार से महंगे हुए एफएमसीजी उत्पाद
उत्पादों के दाम बढ़ने से एफएमसीजी कंपनियों की बिक्री हो सकती है प्रभावित, मगर उनके पास कोई और विकल्प नहीं
Remogliflozin, vildagliptin, metformin FDC approved for Type 2 Diabetes in India
Mumbai-based drumaker Glenmark Pharmaceuticals received approval for its fixed dose combination (FDC) of remogliflozin (100 mg), vildagliptin (50 mg) and metformin (500/ 1000 mg from the Drug Controller General of India.
The press is making it harder for women to come forward
Last Monday, Conservative MP Caroline Nokes told Sky News that Stanley Johnson, the prime minister’s father, had once smacked her “on the backside about as hard as he could” at an event.
‘You cannot reach people effectively if you are not understood'
WITH a career sprawling over four decades, Indian politician and writer Shashi Tharoor has penned a number of books on diverse themes.